It is suggested that lung cancer patients harboring both the 309T (WT) allele in the MDM2 gene and the –617A allele in the NRF2 gene have better prognosis owing to well-controlled tumor suppression via cell cycle arrest and/or apoptosis mediated by p53 (WT); refer to Figure 3. This evidence concerns the gene MDM2 and lung carcinoma.